Jeffrey Shuren, MD, JD will serve as keynote speaker for the 9th Annual Utah Life Sciences Summit.  Jeffrey Shuren, MD, JD, will keynote the luncheon session of the 2018 BioUtah Utah Life Sciences Summit. The annual Summit will be held November 1, in Salt Lake City, UT, at the Salt Lake Downtown Marriott at City Creek.

“As one of the country’s fastest growing life sciences sectors, we welcome Dr. Shuren’s visit,” said Richard Ji, vice president of operations at Clinical Innovations and chair of the BioUtah board of directors. “Utah’s life sciences community will be very interested in getting his perspective on the latest regulatory developments and trends that will impact the future of innovation and healthcare.” The Center is responsible for assuring the safety, effectiveness, and quality of medical devices, assuring the safety of radiation-emitting products, and fostering device innovation. As the Center’s Director, Dr. Shuren is at the forefront of advancing new technologies while improving patient care.

Dr. Shuren has held various policy and planning positions within FDA from 1998 to 2009, including Acting Deputy Commissioner for Policy, Planning, and Budget; Associate Commissioner for Policy and Planning; and Special Counsel to the Principal Deputy Commissioner. Dr. Shuren is board certified in Neurology and served as an Assistant Professor of Neurology at the University of Cincinnati.

“I’ve worked closely with Dr. Shuren for years,” said Senator Orrin Hatch, who has been a champion for the life sciences industry in the Senate. “We’re excited to have Dr. Shuren come to our state and get to know the wide range of innovation taking place here – from promising startups to large, established companies. I’m proud of the difference we’re making in patients’ lives.”

In addition to the special luncheon keynote, the Summit will provide expert insight, networking opportunities, educational sessions and inspiration for all segments of the life sciences industry.

“The 2018 BioUtah Utah Life Sciences Summit is shaping up to be an exceptional event,” said Rob Etherington, CEO at Clene Nanomedicine and vice chair of the BioUtah board of directors. “Our speaker line-up is top-notch, reflecting the best in the business.”

Dr. Shuren will join an esteemed roster of presenters, including breakfast keynote A. Marc Harrison, MD, President and CEO of Intermountain Healthcare, Pat Jones, CEO of the Women’s Leadership Institute, John Knotwell, President and CEO, Utah Technology Council, Gary L. Crocker, Chairman, Merrimack Pharmaceuticals and President of Crocker Ventures, and Paul Brooks, Executive Director of the national Regulatory Affairs Professional Society (RAPS).